Healthcare -
Biotechnology - NASDAQ - GB
$ 0.3
-0.892 %
$ 76.8 M
Market Cap
-1.0
P/E
ADAP - TOTAL EQUITY
Total Equity ADAP - Adaptimmune Therapeutics plc
11.8 M
LAST VALUE
-61.96%
2 YEAR CAGR
-37.44%
5 YEAR CAGR
17.26%
10 YEAR CAGR